This will take effect March 10, 2014
Overview and Clinical Utility:
Beginning March 10, 2014, PathGroup Labs will discontinue testing for Clostridium difficile toxins A and B by ELISA methodology and will perform direct detection of toxigenic C. Difficile strains by DNA amplification. The test will be performed Monday through Friday and may be performed on pediatric as well as adult specimens. The DNA amplification method is more sensitive and specific than the ELISA test.
Click Here to read more.